Projecting the Future Diabetes Population Size and Related Costs for the U.S.
暂无分享,去创建一个
Michael O'Grady | Michael J. O'Grady | Anirban Basu | Elbert S. Huang | E. Huang | A. Basu | Michael O’Grady | James C. Capretta
[1] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[2] M. Chin,et al. Improving and Sustaining Diabetes Care in Community Health Centers With the Health Disparities Collaboratives , 2007, Medical care.
[3] R. Helms. Implications of Population Growth on Prevalence of Diabetes: A Look at the Future , 1992, Diabetes Care.
[4] M. Engelgau,et al. Improvements in Diabetes Processes of Care and Intermediate Outcomes: United States, 19882002 , 2006, Annals of Internal Medicine.
[5] Using clinical information to project federal health care spending. , 2009, Health affairs.
[6] R. Devol,et al. An Unhealthy America:The Economic Burden of Chronic Disease , 2007 .
[7] W. O'Fallon,et al. Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. , 1989, Annals of internal medicine.
[8] D. Armstrong,et al. Preventing foot ulcers in patients with diabetes. , 2005, JAMA.
[9] W. O'Fallon,et al. Survival and recurrence after first cerebral infarction , 1998, Neurology.
[10] S. Saydah,et al. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. , 2004, JAMA.
[11] Alan Brennan,et al. Computer Modeling of Diabetes and Its Complications , 2007, Diabetes Care.
[12] M. Davidson. The disproportionate burden of diabetes in African-American and Hispanic populations. , 2001, Ethnicity & disease.
[13] C. Neslusan,et al. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. , 2003, Diabetes care.
[14] R. Stevens,et al. UKPDS 60: Risk of Stroke in Type 2 Diabetes Estimated by the UK Prospective Diabetes Study Risk Engine , 2002, Stroke.
[15] R. Holman,et al. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68) , 2004, Diabetologia.
[16] L S Geiss,et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. , 2001, Diabetes care.
[17] A. Zbrozek,et al. Model of Complications of NIDDM: I. Model construction and assumptions , 1997, Diabetes Care.
[18] R. Holman,et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). , 2001, Clinical science.
[19] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[20] David O Meltzer,et al. The cost-effectiveness of improving diabetes care in U.S. federally qualified community health centers. , 2007, Health services research.
[21] H. King,et al. Global Burden of Diabetes, 1995–2025: Prevalence, numerical estimates, and projections , 1998, Diabetes Care.